7 research outputs found
A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci
Get PDFGenome-wide association studies (GWAS) in European populations have identified genetic risk variants associated with multiple myeloma (MM)
Randomized, open-label, phase 3 study of subcutaneous daratumumab (DARA SC) versus active monitoring in patients (Pts) with high-risk smoldering multiple myeloma (SMM): AQUILA.
No full textPrevalence and survival of smoldering multiple myeloma in the US: Analysis using a national dataset.
No full textTwo phase 3 studies of the oral proteasome inhibitor (PI) ixazomib for multiple myeloma (MM) in the maintenance setting: TOURMALINE-MM3, and -MM4.
No full textClinical utility of the revised international staging system (RISS) in newly diagnosed multiple myeloma.
No full text
